Demant, DK0060738599

Bernstein sets DKK 322 target for Demant stock

Published on 10/20/2026 at 20:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Q3 revenue rose 21.46 percent to DKK 6.624 billion. Demant stock costs EUR 48.39 on October 20, 2026, up 1.45 percent versus the Xetra close.

Analyst target and results

  • Bernstein set a DKK 322.00 target for Demant stock on October 15, 2026.
  • Q3 2026 revenue reached DKK 6.624 billion, up 21.46 percent from Q3 2025.
  • Demant stock costs EUR 48.39 at Lang & Schwarz on October 20, 2026 at 8:42 p.m. CEST, 1.45 percent above the Xetra close of October 19, 2026.
Pop-Art-Comic illustriert Royal Unibrew A/S, ISIN DK0060738599, mit stilisierter Szene eines Braumeisters in bunter Fabrikhalle, Illustration mit AI erstellt.

Bernstein maintained a Hold rating and set a DKK 322.00 price target for Demant on October 15, 2026, according to Markets Insider. The target is 11.05 percent below Demant's DKK 362.00 Nasdaq Copenhagen price on October 20, 2026. Demant stock was trading at EUR 48.39 at Lang & Schwarz on October 20, 2026 at 8:42 p.m. CEST, up 1.45 percent versus the Xetra close of October 19, 2026 at EUR 47.70.

Q3 revenue accelerates

Demant reported Q3 2026 group revenue of DKK 6,624 million, compared with DKK 5,454 million in Q3 2025. That is a calculated increase of 21.46 percent, while organic growth reached 11 percent, according to the company's October 9, 2026 announcement published through Nasdaq Copenhagen. Hearing Aids external revenue increased organically by 17 percent to DKK 2,747 million from DKK 2,350 million.

Stock stays near its yearly high

The DKK 362.00 Nasdaq Copenhagen price on October 20, 2026 stood 0.55 percent below the DKK 364.00 52-week high and 106.86 percent above the DKK 175.00 low. The stock's year-to-date gain was 65.48 percent, while reported volume reached 234,042 shares on October 20, 2026. Demant's market capitalization was DKK 76.3 billion and its price-to-earnings ratio was 46.95 on that date.

Outlook and next reporting date

Demant lifted its 2026 organic growth outlook to 7-8 percent from 6-7 percent and raised EBIT before special items guidance to DKK 4,700-5,000 million from DKK 4,400-4,800 million. The company also resumed share buybacks on October 9, 2026, targeting at least DKK 3 billion by the end of 2027. The full Q3 2026 interim management statement is scheduled for November 3, 2026, after 5:00 p.m. CET, according to the October 9 announcement.

Valuation leaves a split signal

For investors, the contrast is clear: Q3 revenue increased 21.46 percent year over year, while the DKK 322.00 Bernstein target sits below the DKK 362.00 Copenhagen price. The valuation therefore places the analyst target and the latest operating momentum on opposite sides of the current market level.

Trading position

Demant stock was trading at EUR 48.39 at Lang & Schwarz on October 20, 2026 at 8:42 p.m. CEST, 1.45 percent above the Xetra close of October 19, 2026 at EUR 47.70. The further course of trading is shown by the continuously updated real-time quote of Demant stock.

Demant stock facts

  • Company: Demant A/S
  • ISIN: DK0060738599
  • Ticker: DEMANT
  • Primary exchange: Nasdaq Copenhagen
  • Price Lang & Schwarz (as of October 20, 2026, 8:42 p.m. CEST): EUR 48.39
  • Change versus Xetra close: plus 1.45 percent
  • Xetra close (October 19, 2026): EUR 47.70
  • Market capitalization: DKK 76.3 billion (as of October 20, 2026)
  • 52-week range: DKK 175.00-364.00 (as of October 20, 2026)
  • Sector / Industry: Healthcare / Medical Devices

Market context: Current market reports.

More news and analyses on Demant stock

Disclaimer...
en | DK0060738599 | DEMANT | boerse | 70377541 | bgmi